An2 Therapeutics shares owned by Vanguard Group
Quarter-by-quarter ownership of An2 Therapeutics (ANTX) shares owned by Vanguard Group
from 13F filings
Historical chart of Vanguard Group investment in An2 Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including An2 Therapeutics held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in An2 Therapeutics by Vanguard Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $2.2M | 1.0M | 2.15 |
| 2024-03-31 | $3.4M | 1.0M | 3.25 |
| 2023-12-31 | $22M | 1.1M | 20.49 |
| 2023-09-30 | $15M | 940k | 16.08 |
| 2023-06-30 | $4.7M | 553k | 8.50 |
| 2023-03-31 | $5.9M | 602k | 9.87 |
| 2022-12-31 | $5.6M | 589k | 9.53 |
| 2022-06-30 | $1.4M | 182k | 7.75 |
| 2022-03-31 | $1.1M | 75k | 15.07 |